India’s\u00a0Dr Lal Path Labs\u00a0reported a 19 per cent jump in its\u00a0third-quarter\u00a0profit on Thursday, led by continued demand for its bundle test offerings, sending its shares 3 per cent higher.<\/p>\n\n\n\n
The company’s consolidated net profit rose to Rs 96.7 crore ($11.2 million) in the three months to Dec. 31, from Rs 81.3 crore a year earlier, but fell short of analysts’ estimate of Rs 97.69 crore, according to data compiled by LSEG.<\/p>\n\n\n\n
An increasing awareness around health and wellness, coupled with the expansion of diagnostics firms such as Dr Lal Path into smaller cities, has boosted demand for medical tests.<\/p>\n\n\n\n
The company, which operates about 300 testing labs, said the number of samples tested grew 10 per cent during the quarter.\u00a0<\/small><\/p>\n\n\n\n
Dr Lal Path has also benefited from strong demand for its bundle test offerings, which combine tests for multiple diseases such as hyperthyroidism and diabetes, analysts said.<\/p>\n\n\n\n
The company’s revenue from operations met analysts’ estimates and climbed about 11 per cent to Rs 597 crore.<\/p>\n\n\n\n
It declared a dividend of six rupees per share for the fiscal year 2025.<\/p>\n\n\n\n
Rival Metropolis Healthcare is set to report its third-quarter results next week.<\/p>\n\n\n\n
Eqwires Research Analyst<\/a><\/strong><\/p>\n\n\n\n Top-notch SEBI registered research analyst<\/a><\/strong><\/p>\n\n\n\n Best SEBI registered Intraday tips provider <\/a><\/strong><\/p>\n\n\n\n info@eqwires.com<\/strong><\/a><\/p>\n\n\n\n Telegram <\/a>| Facebook <\/a>| Instagram<\/a><\/strong><\/p>\n\n\n\n Call: +91 9624421555 \/ +91 9624461555<\/em><\/strong><\/p>\n\n\n\n www.eqwires.com<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":" India’s\u00a0Dr Lal Path Labs\u00a0reported a 19 per cent jump in its\u00a0third-quarter\u00a0profit on Thursday, led by continued demand for its bundle test offerings, sending its shares 3 per cent higher. The company’s consolidated net profit rose to Rs 96.7 crore ($11.2 million) in the three months to Dec. 31, from Rs 81.3 crore a year earlier, but fell short of analysts’ estimate of Rs 97.69 crore, according to data compiled by LSEG. An increasing awareness around … Continue reading “Dr Lal Path Labs Q3FY25 results: Net profit jumps 19% to Rs 96.7 crore”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":3545,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[74],"tags":[],"class_list":["post-3544","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-sebi-registered-advisory-company"],"_links":{"self":[{"href":"https:\/\/www.eqwires.com\/tutorials\/wp-json\/wp\/v2\/posts\/3544","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.eqwires.com\/tutorials\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.eqwires.com\/tutorials\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.eqwires.com\/tutorials\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.eqwires.com\/tutorials\/wp-json\/wp\/v2\/comments?post=3544"}],"version-history":[{"count":1,"href":"https:\/\/www.eqwires.com\/tutorials\/wp-json\/wp\/v2\/posts\/3544\/revisions"}],"predecessor-version":[{"id":3546,"href":"https:\/\/www.eqwires.com\/tutorials\/wp-json\/wp\/v2\/posts\/3544\/revisions\/3546"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.eqwires.com\/tutorials\/wp-json\/wp\/v2\/media\/3545"}],"wp:attachment":[{"href":"https:\/\/www.eqwires.com\/tutorials\/wp-json\/wp\/v2\/media?parent=3544"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.eqwires.com\/tutorials\/wp-json\/wp\/v2\/categories?post=3544"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.eqwires.com\/tutorials\/wp-json\/wp\/v2\/tags?post=3544"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}